Page 368 - Read Online
P. 368

Marasco et al. Hepatoma Res 2020;6:33  I  http://dx.doi.org/10.20517/2394-5079.2020.01                                          Page 3 of 19


                                 Table 1. Predictive factors for early and late HCC recurrence after liver resection
                                                       Early recurrence  Late recurrence
                                  Tumor related factors
                                    Tumor size            [27-29]           [27-29]
                                    Tumor grade           [29-32]           [29]
                                    Macrovascular invasion  [19,33-35]      [19]
                                    Microvascular invasion  [19,36-39]      [19,37]
                                    Satellite nodules     [40]              -
                                    Tumor-free margins    [41-43]           [41,43]
                                  Biomarkers
                                    AFP                   [32,35,44-46]     [27,28]
                                    Immunomarkers         [47-54]           -
                                    ERASL-pre score       [55]              -
                                    REACH score           [56]              -
                                    SVR                   [57]              [58-60]
                                    HBV replication       [61]              [15,61]
                                    Alcohol intake                          [62,63]
                                  Others
                                    MicroRNAs             [64,65]           -
                                    Imaging factors       [66-75]
                                    IGC15                 -                 [16]
                                    Sarcopenia            [76]              -
                                  NITs
                                    LSM                   -                 [16,26,77]
                                    SSM                   -                 [17]
                                    FIB-4                 -                 [78]
                                    ALBI > 2              [55,79-82]        [78,83,84]
                                    Platelet/spleen length ratio   -        [17]

               HCC: hepatocellular carcinoma; AFP: alpha-fetoprotein; ERASL: early recurrence after surgery for liver tumor; REACH-B: estimates risk of
               HCC in patients with chronic hepatitis B; SVR: sustained virological response; HBV: hepatitis B virus; IGC15: indocyanine green retention
               rate at 15 min; NITs: non-invasive tests; LSM: liver stiffness measurement; SSM: spleen stiffness measurement; FIB4: fibrosis-4 index;
               ALBI: albumin-bilirubin grade


                                                                                                        [28]
               nodules ≥ 5 cm are associated with an increased recurrence rate due to the higher risk of portal vein
               and micro-vascular invasion (MVI) . Besides, vascular invasion represents another good predictor of
                                               [36]
               tumor recurrence [19,27] . It could be defined as macroscopic, when it is visible on imaging or even on gross
               examination, and microscopic, when seen only on histological examination. The presence of macrovascular
                                                                [19]
               invasion is able to reduce the time to recurrence by 4-fold . Moreover, extension of portal vein thrombosis
               is directly related to poor prognosis [33,34] .


               With regard to MVI, it is usually defined as the presence of tumour emboli within the central hepatic vein,
                                                     [12]
               the portal vein, or the large capsular vessels . Unfortunately, this evaluation is subject to great variability
                                                          [37]
               which affects the true incidence of this condition . The presence of MVI is related to an increased risk
               of HCC recurrence [19,38,39] . The main limitation of MVI assessment depends on its timing since it is often
               obtained on resected specimens. MVI can be accurately assessed only on resected specimens, which
               constitutes a strong limitation to such assessment [29,30,35] . Tumor grade (grade 3/3) and tumor size have also
               been associated with early HCC recurrence and are strictly related to MVI [29-32] .

               Several authors have tried to evaluate the usefulness of other pre-operative parameters beyond tumor grade
               in predicting MVI, such as increased alpha-fetoprotein (AFP), L3-AFP and prothrombin induced by vit K
                                                                                                [85]
               absence-II (PIVKA-II) [30,31,35] . Recently, a low concentration of the autophagy-related marker LC3  on HCC
               and adjacent non-tumor tissues has also been found to be a significant predictor of both early and late HCC
               recurrence. A further recent study  evaluated the role of immunohistochemical markers in a large cohort
                                            [47]
               of resected HCC, concluding that 14 factors showed a prognostic role for predicting recurrence, including
   363   364   365   366   367   368   369   370   371   372   373